Recent advances in neonatal cardiac surgery

World Journal of Surgery

Volumn 32, Issue 3, 2008, Pages 340-345

  El Zein, Chawki ^a   Ilbawi, Michel N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; STEROID;

AORTA VALVE DISEASE; CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; GREAT VESSELS TRANSPOSITION; HEART SURGERY; HEART VENTRICLE SEPTUM DEFECT; HUMAN; HYPOPLASTIC LEFT HEART SYNDROME; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LUNG VASCULAR RESISTANCE; NEWBORN SURGERY; PREOPERATIVE PERIOD; PULMONARY HYPERTENSION; PULMONARY VALVE ATRESIA; REVIEW; SURGICAL MORTALITY;

CARDIAC SURGICAL PROCEDURES; FETAL DISEASES; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; INTRAOPERATIVE CARE; POSTOPERATIVE CARE; PULMONARY ARTERY; ULTRASONOGRAPHY, PRENATAL;

EID: 39749092524     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9418-3     Document Type: Review

References (25)

1. Bull C (1999) Current and potential impact of fetal diagnosis on prevalence and spectrum of serious congenital heart disease at term in the UK. British Pediatric Cardiac Association. Lancet 354(9186):1231-1247
2. Rodrigez JG, Holmes R, Martin R, et al. (1998) Prognosis following prenatal diagnosis of heart malformations. Early Hum Dev 52:13-20
3. Day RS, Tani LY, Minich LL, et al. (1995) Congenital heart disease with ductal-dependent systemic perfusion:doppler ultrasonography flow velocities are altered by changes in the fraction of inspired oxygen. J Heart Lung Transplant 14:718-725
4. Kronon MT, Allen BS, Halldorsson A, et al. (1999) L-arginine, prostaglandin, and white cell filtration equally improve myocardial protection in stressed neonatal hearts. J Thorac Cardiovasc Surg 188:665-673
5. Kennen HT, Thiagarajan R, Stephens KE, et al. (2000) Pulmonary function after modified venovenous ultrafiltration in infants:a prospective randomized trial. J Thorac Cardiovasc Surg 119:501-505; discussion 506-507
6. Sakurai H, Maeda M, Sai N, et al. (1999) Extended use of hemofiltration and high perfusion flow rate in cardiopulmonary bypass improves perioperative fluid balance in neonates and infants. Ann Thorac Surg 5:94-100
7. Bronicki RA, Backer CL, Baden HP, et al. (2000) Dexamethasone reduces the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg 69:1490-1495
8. D'Erico CC, Munro HM, Bove EL (1999) Pro: the routine use of aprotinin during pediatric cardiac surgery is a benefit. J Cardiothorac Vasc Anesth 13:782-784
9. Wippermann CF, Schmid FX, Eberle B, et al. (1999) Reduced inotropic support after aprotinin therapy during pediatric cardiac operations. Ann Thorac Surg 67:173-176
10. Borwoski A, Raji MR, Eichstaedt HC, et al. (1998) Myocardial protection by pressure and volume-controlled continuous hypothermic coronary perfusion in combination with esmolol and nitroglycerine for correction of congenital heart defects in pediatric risk patients. Eur J Cardiothorac Surg 14:243-249
11. Del Nido PJ (1997) Myocardial protection for neonates and infants. Ann Thorac Surg 67:878-879
12. Bellinger DC, Wypij D, DuPlessis AJ, et al. (2001) Developmental and neurologic effects of alpha-stat versus pH-stat strategies for deep hypothermic cardiopulmonary bypass in infants. J Thorac Cardiovasc Surg 121:374-383
13. Kirkahm FJ (1998) Recognition and prevention of neurological complications in pediatric cardiac surgery. Pediatr Cardiol 19:331-345
14. Skaryak LA, Lodge AJ, Kirshbom PM, et al. (1996) Low-flow cardiopulmonary bypass produces greater pulmonary dysfunction than circulatory arrest. Ann Thorac Surg 62:284-288
15. Beghetti M, Morris K, Cox P, et al. (1999) Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med 25:1126-1130
16. Miller OI, Tang SF, Keech A, et al. (2000) Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study. Lancet 346(9240):1464-1469
17. Finer NN, Barrinton KJ (2000) Nitric oxide therapy for the newborn infant. Semin Perinatol 24:59-65
18. Skimming JW (1998) Nitric oxide inhalation therapy for newborn infants. Curr Probl Pediatr 28:253-264
19. Jaillard S, Pierrat V, Truffert P, et al. (2000) Two years follow-up of newborn infants after extracorporeal membrane oxygenation (ECMO). Eur J Cardiothorac Surg 18:328-333
20. Rais-Bahrami K, Short BL (2000) The current status of neonatal extracorporeal membrane oxygenation. Semin Perinatol 24:406-417
21. Khan A, Gazzaniga AB (1996) Treatment of low cardiac output syndrome in paediatric patients with cardiac failure. Cardiovasc Surg 83 Suppl 2(1-4):91-100
22. Daebritz SH, Nollert GD, Zurakowski D, et al. (2000) Results of Norwood Stage 1 operation: comparison of hypoplastic left heart syndrome with other malformations. J Thorac Cardiovasc Surg 119:358-367
23. Hraska V, Nosal M, Sykora P, et al. (2000) Results of modified Norwood's operation for hypoplastic left heart syndrome. Eur J Cardiothorac Surg 18:214-219
24. Tweddell JS, Hoffman GM, Fedderly RT, et al. (2000) Patients at risk for low systemic oxygen delivery after the Norwood procedure. Ann Thorac Surg 69:1893-1899
25. Marino BS, Wernovsky G, Rychik J, et al. (1999) Early results of the Ross procedure in simple and complex left heart disease. Circulation 100(19 Suppl III):62-66